These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C. Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K. J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008 [Abstract] [Full Text] [Related]
5. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B. Hu YC, Liu H, Liu XY, Ma LN, Guan YH, Luo X, Ding XC. World J Gastroenterol; 2017 Nov 07; 23(41):7425-7432. PubMed ID: 29151696 [Abstract] [Full Text] [Related]
10. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C. Scand J Clin Lab Invest; 2014 Apr 07; 74(3):240-7. PubMed ID: 24460024 [Abstract] [Full Text] [Related]
12. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B. Ucar F, Sezer S, Ginis Z, Ozturk G, Albayrak A, Basar O, Ekiz F, Coban S, Yuksel O, Armutcu F, Akbal E. Eur J Gastroenterol Hepatol; 2013 Sep 07; 25(9):1076-81. PubMed ID: 23510962 [Abstract] [Full Text] [Related]
13. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection. Chen YP, Hu XM, Liang XE, Huang LW, Zhu YF, Hou JL. J Gastroenterol Hepatol; 2018 Jan 07; 33(1):256-263. PubMed ID: 28452125 [Abstract] [Full Text] [Related]
14. Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C. Cheng CH, Chu CY, Chen HL, Lin IT, Wu CH, Lee YK, Hu PJ, Bair MJ. J Microbiol Immunol Infect; 2020 Aug 07; 53(4):542-549. PubMed ID: 31831303 [Abstract] [Full Text] [Related]
15. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Leung DH, Khan M, Minard CG, Guffey D, Ramm LE, Clouston AD, Miller G, Lewindon PJ, Shepherd RW, Ramm GA. Hepatology; 2015 Nov 07; 62(5):1576-83. PubMed ID: 26223427 [Abstract] [Full Text] [Related]
16. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C. Gökcan H, Kuzu UB, Öztaş E, Saygılı F, Öztuna D, Suna N, Tenlik İ, Akdoğan M, Kaçar S, Kılıç ZM, Kayaçetin E. Turk J Gastroenterol; 2016 Mar 07; 27(2):156-64. PubMed ID: 26853790 [Abstract] [Full Text] [Related]
17. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis. Sheptulina A, Shirokova E, Nekrasova T, Blum H, Ivashkin V. J Gastroenterol Hepatol; 2016 Dec 07; 31(12):1956-1962. PubMed ID: 27059170 [Abstract] [Full Text] [Related]
18. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C. Amorim TG, Staub GJ, Lazzarotto C, Silva AP, Manes J, Ferronato Mda G, Shiozawa MB, Narciso-Schiavon JL, Dantas-Correa EB, Schiavon Lde L. Ann Hepatol; 2012 Dec 07; 11(6):855-61. PubMed ID: 23109448 [Abstract] [Full Text] [Related]